We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+43.29%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.75B
AUM Growth
+$811M
Cap. Flow
+$363M
Cap. Flow %
13.21%
Top 10 Hldgs %
44.65%
Holding
241
New
88
Increased
39
Reduced
33
Closed
64

Top Buys

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$36.2M
2
HYFM icon
Hydrofarm Holdings
HYFM
+$19.6M
3
LUNG icon
Pulmonx
LUNG
+$19.2M
4
SEER icon
Seer Inc
SEER
+$18.7M
5
ABCL icon
AbCellera Biologics
ABCL
+$16.7M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$27M
2
INSP icon
Inspire Medical Systems
INSP
+$11.3M
3
PPD
PPD, Inc. Common Stock
PPD
+$11.1M
4
STAA icon
STAAR Surgical
STAA
+$10.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$9.3M

Sector Composition

Rank Sector Weight
1 Healthcare 34.42%
2 Industrials 1.65%
3 Consumer Staples 0.32%
4 Financials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VAPO
226
PUT
DELISTED
Vapotherm, Inc. Common Stock
VAPO
– –
-12,500
Closed -$2.9M
CSII
227
CALL
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-60,000
Closed -$2.36M
LHCG
228
DELISTED
LHC Group LLC
LHCG
– –
-22,497
Closed -$4.78M
OTIC
229
CALL
DELISTED
Otonomy, Inc.
OTIC
– –
-800
Closed -$3K
OTIC
230
DELISTED
Otonomy, Inc.
OTIC
– –
-1,671,748
Closed -$6.77M
ABMD
231
PUT
DELISTED
Abiomed Inc
ABMD
– –
-17,500
Closed -$4.85M
AGTC
232
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-176,411
Closed -$857K
ITMR
233
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
– –
-190,074
Closed -$3.88M
ALXN
234
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-100,000
Closed -$11.4M
GNMK
235
PUT
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-175,000
Closed -$2.48M
FPRX
236
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-322,452
Closed -$1.52M
PAND
237
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-25,000
Closed -$287K
BMY.RT
238
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-886,222
Closed -$1.99M
IMMU
239
DELISTED
Immunomedics Inc
IMMU
– –
-100,000
Closed -$8.5M
6 7 8 9
10

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2020 Portfolio in Review

As of Q4 2020, Pura Vida Investments held 241 positions worth $2.75B, up 42% from $1.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Pura Vida Investments deployed $363M of net new capital in Q4 2020, opening 88 new positions and adding to 39 existing holdings. Its largest new stake was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Inspire Medical Systems, an estimated $11.3M trimmed.

  • Pura Vida Investments's largest Q4 2020 buy was MedAvail Holdings, Inc. Common Stock: 51,760 shares worth $36.9M.
  • Pura Vida Investments added most to Guardant Health in Q4 2020, an estimated $9.2M increase.
  • Pura Vida Investments's biggest Q4 2020 reduction was Inspire Medical Systems, cutting an estimated $11.3M.
  • Pura Vida Investments fully exited Cooper Companies in Q4 2020, selling an estimated $27M.
  • Pura Vida Investments's ten largest holdings make up 45% of its $2.75B portfolio in Q4 2020.
  • Pura Vida Investments opened 88 new positions and closed 64 in Q4 2020.
  • Pura Vida Investments's portfolio value rose 42% quarter-over-quarter to $2.75B.

Based on Pura Vida Investments's 13F filing for Q4 2020, filed 16 Feb 2021.